Powered by
3D Signatures Inc. Reports Second Quarter 2017 Financial Results
Mar 2, 2017 - GlobeNewswire
Board and Executive Moves

WINNIPEG, Manitoba, March 02, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), today reported operational and financial results for its fiscal second quarter ended December 31, 2016.

Second Quarter Corporate Highlights

On October 19, 2016, 3DS announced its participation in PRECISE, a major clinical trial for prostate cancer diagnosis and management.On October 27, 2016, the Company introduced its Business Advisory Board ("BAB

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox